Biopharmaceutical
Research
Development
Commercialization
Severe
Diseases
Immunology
Neurology
M&A Advisory
Lazard
Full Credential Description
UCB SA. Belgium, Germany. Announced Date 25/09/2006. Closed Date 08/12/2006. Deal value: $5290m. UCB to acquire Schwarz Pharma. Industry: UCB SA is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines and solutions for people with severe diseases in immunology and neurology.